Understanding the Melanocortin System
PT-141 and Melanotan 2 are two of the most frequently referenced peptides in melanocortin-system research, and they are often discussed together because both act as agonists at melanocortin receptors. Despite this shared origin, they are distinct compounds with different receptor-selectivity profiles and different investigational contexts in the published literature. Both are synthetic analogs derived from the natural signalling peptide alpha-MSH, a molecule that interacts with a family of five melanocortin receptors (MC1R through MC5R) implicated in pigmentation, energy balance, inflammation and central signalling pathways.
Because these peptides sit within an overlapping receptor family, researchers frequently compare their binding breadth, potency and downstream pathway activation in controlled models. This article outlines, at a mechanistic and study-design level only, how PT-141 (10mg) and Melanotan 2 (10mg) are characterised in the literature. All content here is provided strictly for research context. These materials are for research use only, not for human or animal consumption.
Recommended Products
Receptor Selectivity and Context
The central distinction investigated across the two compounds is receptor selectivity. Melanotan 2 is generally characterised as a broad, non-selective melanocortin-receptor agonist, engaging MC1R, MC3R, MC4R and MC5R. PT-141 (bremelanotide) is a metabolite-derived analog studied for comparatively greater relative activity at MC4R and MC3R, with reduced engagement of the pigmentation-associated MC1R pathway. This selectivity difference is the primary variable examined in comparative receptor-binding studies.
| Attribute | PT-141 | Melanotan 2 |
|---|---|---|
| Peptide class | Melanocortin agonist (alpha-MSH analog) | Melanocortin agonist (alpha-MSH analog) |
| Primary receptor focus | MC4R / MC3R emphasis in studies | Broad MC1R, MC3R, MC4R, MC5R |
| MC1R (pigmentation pathway) | Reduced relative engagement | Notable engagement in models |
| Research framing | Central-pathway receptor signalling | Broad melanocortin pathway activity |
| Structural note | Cyclic heptapeptide metabolite analog | Cyclic lactam analog |
Researchers studying central melanocortin signalling frequently reference PT-141 because its narrower profile allows cleaner isolation of MC4R-linked pathways. Melanotan 2, by contrast, is often used as a broad-agonist reference point where multi-receptor activation is the object of study. A related signalling molecule sometimes examined alongside these compounds is Kisspeptin (10mg), a neuropeptide studied for its upstream role in hypothalamic signalling cascades that intersect with melanocortin-adjacent research questions. For broader background on neuro-signalling peptides, see our pillar overview of nootropic and neuro research peptides. When designing comparative work, investigators typically control for solubility, reconstitution buffer and receptor-assay conditions, since apparent potency differences can be assay-dependent rather than intrinsic.
Selecting and Handling These
For comparative receptor research, material identity and purity are the primary selection criteria. Peptides in this class are typically supplied as lyophilised powder and characterised by HPLC purity and mass-spectrometry confirmation of molecular weight. When sourcing PT-141 or Melanotan 2, researchers should confirm the certificate of analysis, lot number and stated purity threshold before designing an assay.
Handling considerations common to both include storing lyophilised powder cold and dark, reconstituting with an appropriate sterile diluent, minimising freeze-thaw cycles, and recording reconstitution date to track working-solution stability. Because these are peptide agonists sensitive to degradation, aliquoting after reconstitution helps preserve integrity across a study. Browse the full research peptides catalogue to compare specifications. All materials are for research use only, not for human or animal consumption.